IL74800A - Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL74800A
IL74800A IL74800A IL7480085A IL74800A IL 74800 A IL74800 A IL 74800A IL 74800 A IL74800 A IL 74800A IL 7480085 A IL7480085 A IL 7480085A IL 74800 A IL74800 A IL 74800A
Authority
IL
Israel
Prior art keywords
aryl
oxothieno
tetrahydro
pyridine
esters
Prior art date
Application number
IL74800A
Other languages
English (en)
Other versions
IL74800A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL74800A0 publication Critical patent/IL74800A0/xx
Publication of IL74800A publication Critical patent/IL74800A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL74800A 1984-04-06 1985-04-03 Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them IL74800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843412947 DE3412947A1 (de) 1984-04-06 1984-04-06 Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
IL74800A0 IL74800A0 (en) 1985-07-31
IL74800A true IL74800A (en) 1989-08-15

Family

ID=6232826

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74800A IL74800A (en) 1984-04-06 1985-04-03 Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US4642310A (fr)
EP (1) EP0157324B1 (fr)
JP (1) JPH0633276B2 (fr)
KR (1) KR850007600A (fr)
AT (1) ATE36854T1 (fr)
AU (1) AU569787B2 (fr)
CA (1) CA1255660A (fr)
DE (2) DE3412947A1 (fr)
DK (1) DK163831B (fr)
ES (1) ES8607314A1 (fr)
HU (1) HU191784B (fr)
IL (1) IL74800A (fr)
ZA (1) ZA852561B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311005A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
DE4313690A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0973778A1 (fr) * 1997-03-07 2000-01-26 Novo Nordisk A/S DERIVES DE 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE, LEUR PREPARATION ET LEUR UTILISATION
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
EP1663227A2 (fr) * 2003-09-10 2006-06-07 Synta Pharmaceuticals Corporation Composes de dihydropyridine permettant de traiter ou de prevenir des troubles metaboliques
KR20200130626A (ko) 2019-05-11 2020-11-19 류승문 정현직교 파형과 바이너리 cdma의 융합에 의해 직교도를 높인 변조신호 생성 방법
KR20190060731A (ko) 2019-05-14 2019-06-03 류승문 정현직교 파형과 바이너리 cdma의 융합에 의해 직교도를 높인 변조신호를 소프트웨어로 구현하는 방법
KR20190062338A (ko) 2019-05-17 2019-06-05 류승문 직교정현 파형과 바이너리 cdma가 융합된 음파 변복조 기술

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935220A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft Tetrahydroimidazolo[1,2-a]pyridine derivatives
US3948923A (en) * 1972-03-06 1976-04-06 Bayer Aktiengesellschaft Pentahydroqunolizine derivatives
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
EP0111453A1 (fr) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Dérivés d'amides
EP0111455A3 (fr) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Lactones non-saturés

Also Published As

Publication number Publication date
US4642310A (en) 1987-02-10
ATE36854T1 (de) 1988-09-15
ES8607314A1 (es) 1986-06-01
ES541780A0 (es) 1986-06-01
EP0157324A2 (fr) 1985-10-09
KR850007600A (ko) 1985-12-07
AU4083485A (en) 1985-10-10
DK163831B (da) 1992-04-06
EP0157324B1 (fr) 1988-08-31
JPH0633276B2 (ja) 1994-05-02
IL74800A0 (en) 1985-07-31
DE3564684D1 (en) 1988-10-06
DK154385D0 (da) 1985-04-03
HUT37797A (en) 1986-02-28
AU569787B2 (en) 1988-02-18
JPS60228485A (ja) 1985-11-13
HU191784B (en) 1987-04-28
DE3412947A1 (de) 1985-10-17
EP0157324A3 (en) 1987-06-16
DK154385A (da) 1985-10-07
CA1255660A (fr) 1989-06-13
ZA852561B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
NO863823D0 (no) 1,5-benzothiazepinderivater som er anvendelige som utgangsmaterialer ved fremstilling av nye, terapeutisk aktive 8-klor-1,5-benzothiazepinderivater, og fremgangsmaate ved deres fremstilling.
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
DK157785A (da) 1,5-benzothiazepinderivater og fremgangsmaade til deres fremstilling
IL74800A (en) Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
DK179788D0 (da) N-aryl-piperazinalkanamidderivater, fremgangsmaade til fremstilling deraf, praeparater indeholdende samme samt anvendelse af saadanne derivater til fremstilling af farmaceutisk aktive praeparater
ATE32221T1 (de) 3 n-substituierte 3,4-dihydropyrimidinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
BR8400549A (pt) Derivados e sais inertes de hidroxido de aminopiridinios e processos de preparacao;e composicao farmaceutica
PT84680A (fr) Procede de preparation de derives 1,5-benzothiazepine et de compositions pharmaceutiques les contenant
ZA857457B (en) Furo(3,2-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them
NO883262D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO176608C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidinylindazol-derivater
HUT44500A (en) Process for producing methionin-substituted new 1,4-dihydro-pyridine derivatives and pharmaceutical compositions containing them
WO1987004435A3 (fr) Composes de xanthine
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
IT1130997B (it) Esteri e derivati chinucleidinici di acidi fenossicarbossilici,procedimento per la loro preparazione e relative composizioni farmaceutiche
SE8505801L (sv) I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa
IL85508A (en) 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them